ii effect aph 3 rsquo ii fresh tomato therapeut efficaci oral administ antibiot calgen perform sever experi intend address whether aph 3 rsquo ii consum compon fresh tomato could render oral administ kanamycin ineffect experi perform simul gastric intestin condit e appropri ph reagent concentr temperatur reaction time chosen reflect condit expect vivo studi tomato extract nonfat milk ad determin whether presenc addit food sourc protein simul gastric intestin fluid might slow proteolyt degrad aph 3 rsquo ii competit evalu loss immunolog detect aph 3 rsquo ii calgen conclud normal gastric intestin condit aph 3 rsquo ii would effect degrad enzym could inactiv kanamycin neomycin therefor aph 3 rsquo ii would interfer oral administ kanamycin neomycin therapi result calgen experi whether done presenc absenc tomato extract nonfat milk addit calgen present result vitro degrad studi perform simul abnorm gastric condit may exist patient treat drug reduc stomach acid calgen state studi demonstr aph 3 rsquo ii degrad neutral ph 7 0 simul gastric fluid thu aph 3 rsquo ii may remain activ abnorm gastric condit howev calgen point even condit aph 3 rsquo ii would expect inactiv oral administ kanamycin neomycin concentr atp enzym requir inactiv kanamycin neomycin would limit support content calgen present data publish literatur atp level fresh fruit veget calgen estim atp intak calcul fraction neomycin would phosphoryl assum avail atp react antibiot worst case situat high intak atp contain food low dose antibiot calgen calcul show small fraction 1 5 percent antibiot would inactiv moreov calgen present data show signific inactiv kanamycin observ vitro studi conduct tomato extract contain aph 3 rsquo ii kanamycin 4 hour incub period iii agenc conclus agenc evalu data inform present calgen ref 18 21 24 fda agre calgen vitro digest studi show case dietari protein gener biolog activ aph 3 rsquo ii destroy gastric intestin phase digest agenc determin activ aph 3 rsquo ii might remain would significantli inactiv kanamycin neomycin gut small amount atp fruit veget would limit amount antibiot could phosphoryl atp extrem labil molecul suscept inactiv heat e g cook enzym alkalin phosphatas ref 25 found intestin atp meat poultri fish cook veget would broken cook primari sourc atp gastrointestin gi tract patient would uncook fruit veget howev amount atp varieti fruit veget would provid enough atp inactiv small percentag kanamycin neomycin even one make conserv assumpt atp fruit veget would surviv alkalin phosphatas intestin would avail catalyt phosphoryl kanamycin neomycin addit agenc consid patient popul like expos aminoglycosid antibiot oral aminoglycosid commonli administ either pre oper patient prior bowel surgeri patient hepat encephalopathi neither patient popul would expect ingest tomato fresh fruit veget therefor littl risk inactiv oral antibiot patient ref 24 26 reason fda conclud presenc aph 3 rsquo ii food compromis therapeut use oral administ kanamycin neomycin